<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aims to investigate the relationship between the circulating level of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and body <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> in Japanese patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We measured the body mass index (BMI), waist and hip circumferences, visceral and subcutaneous <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposities</z:e>, visceral/subcutaneous (V/S) <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> ratio, and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> as assessed by the Homeostasis Model Assessment (HOMA) index in patients with <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The study group consisted of 17 Japanese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> (age: 62+/-10 years, mean+/-S.D.), and the control group consisted of 24 age-matched type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients with normohomocysteinemia (60+/-11 years) </plain></SENT>
<SENT sid="3" pm="."><plain>The visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, HOMA index, and V/S ratio were significantly higher in the <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> group than in the normohomocysteinemia group (P&lt;0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, the BMI, hip circumference, and subcutaneous <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> were similar between the two groups (P&gt;0.1) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, multiple regression analysis showed that <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> was closely related to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Our results indicate that the presence of <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> in our population of Japanese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>-associated <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> was associated with increased visceral but not subcutaneous <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> </plain></SENT>
</text></document>